← All stocks

Corbus Pharmaceuticals Holdings, Inc.

CRBP Net selling

CIK 0001595097 #3966 in the set updated 17 Sep 2026

Bought (12 mo)

$126.25K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$1.69M

$525.70K on a plan · $713.87K straight out of an exercise

Sold at will

$446.98K

5 of 17 sales

Net

−$1.56M

−$320.72K against sales at will

By person

14 insiders · 20 transactions

1.9×

Yuval Cohen holds only 1.9 times base salary in stock. $1.23M of shares against $646.57K in salary for 2025.

Salary from the company's own proxy. The shares are what Yuval Cohen last reported holding, valued at $7.84, the price Common Stock, par value $0.0001 per share was last bought or sold at on the open market here, on 14 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Cohen Yuval

Chief Executive Officer

—

$750.55K (4) scheduled

−$750.55K

157,316

0.8134%

$1.23M

+103.7%

Moran Sean F.

Chief Financial Officer

—

$378.50K (3) scheduled

−$378.50K

84,694

0.4379%

$664.13K

+74.2%

Cormorant Asset Management, LP entity

10% owner

—

$344.01K (1)

−$344.01K

2,344,971

12.12%

$18.39M

+15.8%

Saxena Nishant C

Chief Business Officer

$126.25K (3)

—

+$126.25K

77,900

0.4028%

$610.85K

+2,126%

Smethurst Dominic

Chief Medical Officer

—

$77.18K (2)

−$77.18K

89,790

0.4642%

$704.09K

+79.6%

Altmeyer Anne

Director

—

$40.82K (2) scheduled

−$40.82K

7,579

0.0392%

$59.43K

+172.3%

Jenkins John Kenneth

Director

—

$37.99K (1) scheduled

−$37.99K

3,833

0.0198%

$30.06K

+36.1%

Hodgson Ian

Chief Operating Officer

—

$25.79K (2)

−$25.79K

51,080

0.2641%

$400.54K

+96.6%

Kung Winston

Director

—

$16.03K (1) scheduled

−$16.03K

12,140

0.0628%

$95.20K

+118.1%

Ben Yong

Director

—

$15.68K (1) scheduled

−$15.68K

9,383

0.0485%

$73.58K

+237.2%

Nicacio Leonardo Viana

Chief Medical Officer

—

58,333

0.3016%

$457.42K

—

Jacques Rachelle Suzanne

Director

—

11,383

0.0589%

$89.26K

+309.0%

HOLMER ALAN F

Director

—

10,629

0.0550%

$83.35K

+82.3%

Pfeiffenberger Brent

Director

—

7,500

0.0388%

$58.81K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Smethurst Dominic

2 Mar 2026

Chief Medical Officer

Sell

6,097

$8.30

$50.60K

Hodgson Ian

17 Feb 2026

Chief Operating Officer

Sell

847

$7.38

$6.25K

Hodgson Ian

3 Feb 2026

Chief Operating Officer

Sell

2,415

$8.09

$19.54K

Smethurst Dominic

3 Feb 2026

Chief Medical Officer

Sell

3,285

$8.09

$26.57K

Cormorant Asset Management, LP

11 Dec 2025

10% owner

Sell indirect

30,029

$11.46

$344.01K

Show all 20 transactions →

Corbus Pharmaceuticals Holdings, Inc.

By person

Individual transactions

What was left out